Our client's mission is to systematically map and discover high-value, high-impact medicines inspired by nature to transform human health. Working at the molecular level requires breakthrough knowledge-assembly, machine learning, and metabolomics technologies developed by their core team. In the industry, understanding the medicinal value of natural substances has led to serendipitous successes like aspirin and quinine, and more recently CBD and ibogaine. However, no platform has existed for the consistent, deterministic discovery of these paradigm-shifting compounds - until now.
Feb 12, 2021